Acorah Software Products - Accounts Production 19.3.550 false true 31 July 2024 1 August 2023 false 1 August 2024 31 July 2025 31 July 2025 13531809 Mr Abbas Fazal Mr Shahbaz Mirza Mr Ishaq Ali Mr Ka Wai Poon iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13531809 2024-07-31 13531809 2025-07-31 13531809 2024-08-01 2025-07-31 13531809 frs-core:CurrentFinancialInstruments 2025-07-31 13531809 frs-core:Non-currentFinancialInstruments 2025-07-31 13531809 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2025-07-31 13531809 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 13531809 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-07-31 13531809 frs-core:ShareCapital 2025-07-31 13531809 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 13531809 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 13531809 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 13531809 frs-bus:SmallEntities 2024-08-01 2025-07-31 13531809 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 13531809 frs-bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 13531809 frs-core:UnlistedNon-exchangeTraded 2025-07-31 13531809 frs-core:UnlistedNon-exchangeTraded 2024-07-31 13531809 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-07-31 13531809 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-07-31 13531809 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-07-31 13531809 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-07-31 13531809 frs-bus:Director1 2024-08-01 2025-07-31 13531809 frs-bus:Director2 2024-08-01 2025-07-31 13531809 frs-bus:Director3 2024-08-01 2025-07-31 13531809 frs-bus:Director4 2024-08-01 2025-07-31 13531809 frs-countries:EnglandWales 2024-08-01 2025-07-31 13531809 2023-07-31 13531809 2024-07-31 13531809 2023-08-01 2024-07-31 13531809 frs-core:CurrentFinancialInstruments 2024-07-31 13531809 frs-core:Non-currentFinancialInstruments 2024-07-31 13531809 frs-core:ShareCapital 2024-07-31 13531809 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31
Registered number: 13531809
Pharmagennex Enterprises Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 13531809
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 95,000 95,000
Investments 5 520,637 520,637
615,637 615,637
CURRENT ASSETS
Stocks 6 1,000 -
Debtors 7 450 450
Cash at bank and in hand 245 388
1,695 838
Creditors: Amounts Falling Due Within One Year 8 (270,924 ) (242,047 )
NET CURRENT ASSETS (LIABILITIES) (269,229 ) (241,209 )
TOTAL ASSETS LESS CURRENT LIABILITIES 346,408 374,428
Creditors: Amounts Falling Due After More Than One Year 9 (374,606 ) (395,562 )
NET LIABILITIES (28,198 ) (21,134 )
CAPITAL AND RESERVES
Called up share capital 10 100 100
Profit and Loss Account (28,298 ) (21,234 )
SHAREHOLDERS' FUNDS (28,198) (21,134)
Page 1
Page 2
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Abbas Fazal
Director
28/07/2026
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Pharmagennex Enterprises Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13531809 . The registered office is 36 Oxford Drive, Acocks Green, Birmingham, West Midlands, B27 6SH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold Not depreciated
2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Tangible Assets
Land & Property
Freehold
£
Cost
As at 1 August 2024 95,000
As at 31 July 2025 95,000
Net Book Value
As at 31 July 2025 95,000
As at 1 August 2024 95,000
Page 3
Page 4
5. Investments
Unlisted
£
Cost or Valuation
As at 1 August 2024 520,637
As at 31 July 2025 520,637
Provision
As at 1 August 2024 -
As at 31 July 2025 -
Net Book Value
As at 31 July 2025 520,637
As at 1 August 2024 520,637
Unlisted investment relates to the purchase of 100% of the share capital of Primulus Limited, a company registered in England under company number 04593252.
6. Stocks
2025 2024
£ £
Stock 1,000 -
7. Debtors
2025 2024
£ £
Due within one year
Other debtors 450 450
8. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Bank loans and overdrafts 22,711 24,467
Other creditors 694 694
Accruals and deferred income 1,300 850
Directors' loan accounts 11,090 11,097
Amounts owed to subsidiaries 235,129 204,939
270,924 242,047
Page 4
Page 5
9. Creditors: Amounts Falling Due After More Than One Year
2025 2024
£ £
Bank loans 374,606 395,562
10. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
11. Related Party Transactions
During the year, the company charged its subsidiary company, Primulus Ltd (Co. No. 04593252), £27,000 as rent for use of its premises. 
Page 5